The title compounds C 17 H 14 BrNO 2 , (I), and C 17 H 15 NO 3 , (II), were obtained from the reaction of 6-methoxy-3,4-dihydro-2H-naphthalen-1-one and 2-bromonicotinaldehyde in ethanol. Compound (I) was the expected product and compound (II) was the oxidation product from air exposure. In the crystal structure of compound (I), there are no short contacts or hydrogen bonds. The structure does display -interactions between adjacent benzene rings and adjacent pyridyl rings. Compound (II) contains two independent molecules, A and B, in the asymmetric unit; both are non-planar, the dihedral angles between the methoxybenzene and 1H-pyridin-2-one mean planes being 35.07 (9) in A and 35.28 (9) in B. In each molecule, the 1H-pyridin-2-one unit participates in intermolecular N-HÁ Á ÁO hydrogen bonding to another molecule of the same type (A to A or B to B). The structure also displays -interactions between the pyridyl and the benzene rings of non-equivalent molecules (viz., A to B and B to A).
Chemical context
In order to address the need for new therapeutic agents, medicinal chemists have often looked to nature for inspiration. Our research strategy to synthesize novel compounds considered analogs of the natural product chalcone, which contains two aromatic rings and an --unsaturated ketone. Chalcones, bioactive defense molecules found in plants and used in traditional Chinese medicine, have demonstrated anticancer, antibacterial, antifungal, and anti-inflammatory properties (Nowakowska, 2007; Katsori et al., 2011) . Chalcones that contain methoxy groups (Shenvi et al., 2013; Bandgar et al., 2010) and/or pyridine groups (Prasad et al., 2008; Yee et al., 2005) have demonstrated activity against a variety of cancer cell lines and antibiotic-resistant bacteria. Thus, we set out to create a library of chalcones that combine those two functional groups. During the synthesis of the title compound (I) by the Claisen-Schmidt condensation of 6-methoxy-3,4-dihydro-2H-naphthalen-1-one and 2-bromonicotinaldehyde, two different types of crystals were obtained -those of the desired chalcone (I) and those of the oxidized product (II). The title compound (I) is a chalcone analog of one currently being studied for its potential anticancer and antibacterial activity [unpublished results] . ISSN 2056-9890 
Structural commentary
Compound (I) is non-planar ( Fig. 1) with the pyridyl and the benzene ring being rotated by 73.61 (11) . The C1-Br1 bond distance is 1.916 (4) Å . In compound (II), which presents two independent molecules in the asymmetric unit (A and B, Fig. 2 ), the Br atom is replaced by an oxygen atom, with C-O distances O1A-C1A = 1.258 (3) and O1B-C1B = 1.257 (3) Å . The molecules are also non-planar, the benzenepyridyl angle being 36.18 (10) in A and 35.91 (10) in B.
Supramolecular features
In the crystal structure of (I), molecules are linked by BrÁ Á Á and -interactions. The Br1Á Á ÁCg1 i distance is 3.635 (3) Å [symmetry code: (i) À1 + x, y, z; Cg1 is the centroid of the benzene ring] and has a 'face-on' geometry. There are twointeractions in the crystal between adjacent benzene rings, Cg1Á Á ÁCg1 ii = 3.944 (4) Å [symmetry code: (ii) 1 À x, 1 À y, 1 À z] and between adjacent pyridyl rings, Cg2Á Á ÁCg2 iii = 3.639 (4) Å [symmetry code: (iii) Àx, 1 À y, Àz]. Theinteractions form ribbons in the (101) plane (Fig. 3) , which are held together by the BrÁ Á Á interactions (Fig. 4) .
In each one of the independent molecules in (II), the 1H-pyridin-2-one unit participates in intermolecular N-HÁ Á ÁO hydrogen bonding, with a classical R A view of the molecular structure of compound (I), showing the atom and ring labeling. Displacement ellipsoids are drawn at the 50% probability level.
Figure 2
A view of the molecular structure of compound (II), showing the atom and ring labeling. Displacement ellipsoids are drawn at the 50% probability level.
Figure 3
A view of hydrogen-bonded dimers formed in compound (II). Only molecule A is shown, for simplicity. Hydrogen bonds (see Table1) are drawn with dashed lines.
Table 1
Hydrogen-bond geometry (Å , ) for (II). B-A interactions) (Fig. 6) ; Cg3Á Á ÁCg4 i = 3.875 (4) and Cg5Á Á ÁCg6 ii = 3.857 (4) Å [symmetry codes: (i) 3 À x, 1 À y, Àz; (ii) 1 À x, 1 À y, 1 À z; Cg3 and Cg4 are the centroids of the pyridyl and benzene rings of molecule A, Cg5 and Cg6 are the corresponding centroids in molecule B].
Database survey
A search of the Cambridge Structural Database (Version 5.37 with four updates, Groom et al., 2016) for structures containing the combined tetralone and pyridine backbone returned no hits. The search was broadened by changing the nitrogen to carbon, which returned 43 hits. The carboncontaining version of (I) has been reported (Dimmock et al., 2002; Yee et al., 2005) . Many of these similar chalcones also demonstrated biological activities (Dimmock et al., 2002) .
Synthesis and crystallization
6-Methoxy-3,4-dihydro-2H-naphthalen-1-one (1 mmol) and 2-bromonicotinaldehyde (1 mmol) were dissolved in ethanol (5 mL). An NaOH solution (5 M, 1 mL) was added and the reaction was stirred until a precipitate formed. The reaction mixture was cooled in an ice bath for 20 minutes. The solids were filtered off and recrystallized from MeOH/H 2 O. Slow evaporation of a methanolic solution gave dark purple/brown crystals, which proved to be 3-[(E)-(6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-idene)methyl]pyridin-2(1H)-one, (II), and lighter purple crystals which proved to be (E)-2-[(2-bromopyridin-3-yl)methylidene]-6-methoxy-3,4-dihydronaphthalen-1(2H)-one, (I).
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . All H atoms were positioned geometrically and refined as riding with C-H = 0.95 or 0.98 Å and U iso (H) = 1.2U eq (C). The hydrogen-bonded units in (II) are linked by -stacking interactions between the phenyl and pyridyl rings in adjacent molecules of different type. For both compounds, data collection: CrystalClear-SM Expert (Rigaku, 2011 ); cell refinement: CrystalClear-SM Expert (Rigaku, 2011) ; data reduction: CrystalClear-SM Expert (Rigaku, 2011 ) is used only for calculating Rfactor (gt). (7) 0.0041 (7) −0.0016 (7) O1B 0.0326 (9) 0.0290 (9) 0.0324 (9) 0.0070 (7) 0.0039 (7) 0.0002 (7 
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